CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions | Total | Common Stock | Treasury Shares | Paid-In Capital | Accumulated Other Comprehensive Income | Retained Earnings |
Beginning balance (in shares) at Dec. 31, 2022 | | 768 | | | | |
Beginning balance (in shares) at Dec. 31, 2022 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2022 | $ 12,659 | $ 77 | $ 0 | $ 7,933 | $ 13 | $ 4,636 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 677 | | | | | 677 |
Stock amortization and vesting | 13 | | | 13 | | |
Conversion of Cimarex redeemable preferred stock | 3 | | | 3 | | |
Common stock repurchases (in shares) | | | 11 | | | |
Common stock repurchases | (271) | | $ (271) | | | |
Common stock retirements (in shares) | | (11) | (11) | | | |
Common stock retirements | 0 | $ (1) | $ (271) | (270) | | |
Cash dividends on common stock | (438) | | | | | (438) |
Ending balance (in shares) at Mar. 31, 2023 | | 757 | | | | |
Ending balance (in shares) at Mar. 31, 2023 | | | 0 | | | |
Balance at end of period at Mar. 31, 2023 | 12,643 | $ 76 | $ 0 | 7,679 | 13 | 4,875 |
Beginning balance (in shares) at Dec. 31, 2022 | | 768 | | | | |
Beginning balance (in shares) at Dec. 31, 2022 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2022 | 12,659 | $ 77 | $ 0 | 7,933 | 13 | 4,636 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 886 | | | | | |
Ending balance (in shares) at Jun. 30, 2023 | | 755 | | | | |
Ending balance (in shares) at Jun. 30, 2023 | | | 0 | | | |
Balance at end of period at Jun. 30, 2023 | 12,659 | $ 76 | $ 0 | 7,639 | 13 | 4,931 |
Beginning balance (in shares) at Mar. 31, 2023 | | 757 | | | | |
Beginning balance (in shares) at Mar. 31, 2023 | | | 0 | | | |
Balance at beginning of period at Mar. 31, 2023 | 12,643 | $ 76 | $ 0 | 7,679 | 13 | 4,875 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 209 | | | | | 209 |
Stock amortization and vesting | 17 | | | 17 | | |
Common stock repurchases (in shares) | | | 2 | | | |
Common stock repurchases | (57) | | $ (57) | | | |
Common stock retirements (in shares) | | (2) | (2) | | | |
Common stock retirements | 0 | $ 0 | $ (57) | (57) | | |
Cash dividends on common stock | (153) | | | | | (153) |
Ending balance (in shares) at Jun. 30, 2023 | | 755 | | | | |
Ending balance (in shares) at Jun. 30, 2023 | | | 0 | | | |
Balance at end of period at Jun. 30, 2023 | 12,659 | $ 76 | $ 0 | 7,639 | 13 | 4,931 |
Beginning balance (in shares) at Dec. 31, 2023 | | 751 | | | | |
Beginning balance (in shares) at Dec. 31, 2023 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2023 | 13,039 | $ 75 | $ 0 | 7,587 | 11 | 5,366 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 352 | | | | | 352 |
Stock amortization and vesting | 15 | | | 15 | | |
Common stock repurchases (in shares) | | | 6 | | | |
Common stock repurchases | (157) | | $ (157) | | | |
Common stock retirements (in shares) | | (6) | (6) | | | |
Common stock retirements | 0 | $ 0 | $ (157) | (157) | | |
Cash dividends on common stock | (160) | | | | | (160) |
Ending balance (in shares) at Mar. 31, 2024 | | 745 | | | | |
Ending balance (in shares) at Mar. 31, 2024 | | | 0 | | | |
Balance at end of period at Mar. 31, 2024 | 13,089 | $ 75 | $ 0 | 7,445 | 11 | 5,558 |
Beginning balance (in shares) at Dec. 31, 2023 | | 751 | | | | |
Beginning balance (in shares) at Dec. 31, 2023 | | | 0 | | | |
Balance at beginning of period at Dec. 31, 2023 | 13,039 | $ 75 | $ 0 | 7,587 | 11 | 5,366 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 572 | | | | | |
Ending balance (in shares) at Jun. 30, 2024 | | 740 | | | | |
Ending balance (in shares) at Jun. 30, 2024 | | | 0 | | | |
Balance at end of period at Jun. 30, 2024 | 13,029 | $ 74 | $ 0 | 7,324 | 11 | 5,620 |
Beginning balance (in shares) at Mar. 31, 2024 | | 745 | | | | |
Beginning balance (in shares) at Mar. 31, 2024 | | | 0 | | | |
Balance at beginning of period at Mar. 31, 2024 | 13,089 | $ 75 | $ 0 | 7,445 | 11 | 5,558 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 220 | | | | | 220 |
Exercise of stock options | 1 | | | 1 | | |
Stock amortization and vesting | 16 | | | 16 | | |
Common stock repurchases (in shares) | | | 5 | | | |
Common stock repurchases | (139) | | $ (139) | | | |
Common stock retirements (in shares) | | (5) | (5) | | | |
Common stock retirements | 0 | $ (1) | $ (139) | (138) | | |
Cash dividends on common stock | (158) | | | | | (158) |
Ending balance (in shares) at Jun. 30, 2024 | | 740 | | | | |
Ending balance (in shares) at Jun. 30, 2024 | | | 0 | | | |
Balance at end of period at Jun. 30, 2024 | $ 13,029 | $ 74 | $ 0 | $ 7,324 | $ 11 | $ 5,620 |